Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

131 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-03-15

Study Completion Date

2020-07-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

By applying polymerase chain reaction (PCR) test for Covid-19 to preeclampsia patients who applied to our hospital during the Covid-19 pandemic period, we investigated the frequency of Covid-19 related preeclampsia-like syndrome in this patient group.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prognosis in Pregnant With COVID-19

NCT04409249

COVID-19 Prognostic Factors Pregnancy

COMPLETED

Perinatal Outcomes and Hematologic Parameters in COVID-19 Pregnancies

NCT04515108

Pregnancy, Infections in Covid19

COMPLETED

Early Onset Preeclampsia and Nectin-4

NCT05098691

Pre-Eclampsia Early Onset Preeclampsia Oxidative Stress +1 more

COMPLETED

Clinical Study of Pregnant Women With COVID-19

NCT04701944

Covid-19

UNKNOWN

Covid-19 Infection in Pregnancy

NCT04869202

Perinatology

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators studied the frequency of Covid-19 related preeclampsia-like syndrome by PCR test and lung ultrasound for Covid-19 to preeclampsia patients presenting to the instutution during the Covid-19 pandemic period. The first consecutive 100 preeclampsia patients presented to our hospital during the pandemic will be involved in our study. The primary outcome measure is to detect Covid-19 positivity among the preeclamptic pregnant women..

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Covid-19 Preeclampsia Pregnancy Related

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PCR, lung ultrasound

PCR for Covid-19

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* First consecutive 100 pregnant women presenting with preeclamptic symptoms and signs between March 15, 2020 and June 1, 2020.

Exclusion Criteria

* The pregnancies with known diagnosis of preeclampsia before Covid-19 pandemic
* Preeclamptic patient without a Covid-19 PCR test result
* Pregnant women who does not want to participate in study or does not want their personal informations to be shared
* Pregnant women less than 18 years old and more than 40 years old are excluded

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No